靜脈輸液治療市場－全球產業規模、佔有率、趨勢、機會、預測：按服務、按組件、按最終用戶產業、按地區和競爭對手分類，2021-2031年

全球靜脈輸液（IV）補液療法市場預計將從 2025 年的 31.6 億美元成長到 2031 年的 49.7 億美元，複合年成長率為 7.84%。

這種療法是將液體、電解質、維生素和藥物直接注入血液，從而實現即時吸收和快速全身補水。市場成長的主要促進因素是需要營養支持的慢性疾病日益增多，以及消費者對預防性健康管理和運動後恢復的關注度顯著提高。非醫院服務場所（例如專業健康診所和行動輸液服務提供者）的擴張進一步推動了這一趨勢。美國醫療美容協會報告稱，作為選擇性靜脈輸液療法主要提供者的醫療美容機構，其年均收入在2024年達到1,398,833美元，這體現了該行業的強勁經濟實力。

儘管行業發展迅速，但仍面臨法律規範和安全標準合規的重大挑戰。隨著靜脈輸液治療從臨床醫院轉向商業機構，對服務提供者的工作範圍和無菌配製標準合規性的審查也日益嚴格。這種複雜的法規結構為新參與企業帶來了法律責任風險和營運障礙，並可能阻礙在醫療監管要求嚴格的地區進行獨立輸液服務的擴充性。

市場促進因素

醫療水療中心和美容健康診所的快速擴張是市場成長的主要驅動力，有效地將靜脈輸液療法從急性護理轉變為主流生活方式服務。這一演變的特點是專業水合中心積極開展特許經營，並將靜脈輸液服務整合到現有的美容業務中，從而擴大了非醫療相關人員的可及性。 SharpSheets 在 2025 年 10 月發布的報告《Restore Hyper Wellness 特許經營資訊揭露文件、收入和成本（2025）》中指出，這些實體店的經濟可行性得到了支撐，特許經營店的平均年收入約為 851,000 美元。這個實體店網路正因技術主導的行動服務而顯著增強，這些服務可將治療送至家庭和辦公室。 Hydreight Technologies 在 2025 年 12 月發布的《公司最新動態：第三季強勁勢頭》中指出，其季度營收達到 1,052 萬美元，年成長 132%，證明了其分散式模式的擴充性。

同時，消費者對預防性健康日益成長的偏好正在重塑市場需求，人們不再僅僅關注被動的醫療護理，而是將免疫力、認知功能和運動表現置於首位。這一趨勢在活躍的專業中尤其明顯，他們將靜脈營養不僅作為疾病治療手段，更將其視為日常健康最佳化的工具。這一轉變在預約趨勢中得到了清晰的體現。 ClassPass 於 2025 年 12 月發布的年度報告顯示，全球運動恢復療程的預約量年增了 155%。為了因應這一趨勢，服務提供者正在拓展服務範圍，提供特製的營養液，靜脈輸液療法在整體健康經濟中佔據了穩固的地位，同時也促進了常規預防性使用。

市場挑戰

法律規範和安全標準缺乏統一性，導致商業環境不穩定，嚴重阻礙了全球靜脈輸液治療市場的成長。隨著該行業從傳統醫院轉向商業健康中心和移動醫療車，監管機構正在加強對無菌配製通訊協定和執業範圍相關法律的執行力度。這種碎片化導致機構標準和提供者合格方面出現混亂，迫使營運商在複雜且成本高昂的法律環境中艱難前行，而這些法律環境在不同司法管轄區之間差異顯著。因此，營運商面臨更高的責任風險，被迫將大量資金用於合規，而非服務創新或區域擴張。

這些合規義務為市場擴張帶來了不成比例的負擔，而市場擴張的驅動力正是服務場所激增，但這些場所卻缺乏醫院等機構基礎設施。積極的商業性成長與嚴格的醫療監管要求之間的矛盾，為尋求滿足消費者需求的新進入者造成了巨大的瓶頸。這一問題的嚴重性體現在受此類監管的機構數量上。美國醫療水療協會預測，到2025年，美國醫療水療機構的數量將達到11,553家。在如此龐大且不斷擴張的服務提供者網路中，缺乏統一的監管標準直接阻礙了產業整合和投資者信心的提升。

市場趨勢

對NAD+和延年益壽通訊協定的需求顯著成長，正在重塑服務格局，顯示市場正從簡單的補水轉向先進的抗衰老齡化干預。消費者越來越尋求能夠修復細胞、支持粒線體功能和提升認知能力的「生物駭客」療法，這迫使供應商拓展服務範圍，不再局限於傳統的維生素補充劑。這一趨勢得益於主要上游供應商強勁的財務表現。例如，ChromaDex在2025年3月發布的2024年第四季及全年財報中揭露，其淨銷售額為9,960萬美元，年增19%，這主要得益於其NAD+前體產品在健康產業和臨床應用領域的廣泛應用。

同時，隨著訂閱和會員製經營模式的普及，該行業正經歷結構性變革。服務提供者正積極從一次性急性照護收入轉向能夠提供可預測現金流並提高長期客戶維繫率的循環付費模式。事實證明，這項策略對主要市場參與者行之有效。正如Athletech News在其2025年5月發布的《健康與康復展望》報導中所指出的，Restore Hyper Wellness報告稱，其在2024年擁有超過57,000名活躍會員，並實現了2億美元的年度系統總收入。這些會員計劃鼓勵用戶持續使用，並有效地將偶爾使用的用戶轉化為積極的生活方式消費者。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球靜脈輸液（IV）水化療法市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 服務類別（增強免疫系統、補充能量、護膚、偏頭痛治療、其他）
  • 依成分（含藥、不含藥）
  • 按行業分類的最終用戶（醫院/診所、健康中心/水療中心、居家醫療、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美靜脈輸液（IV）水化療法市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲靜脈輸液（IV）水化療法市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區靜脈輸液（IV）補液療法市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲靜脈輸液療法市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲靜脈輸液（IV）水化療法市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球靜脈輸液治療市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Core IV Therapy, LLC
• Rejuvenated UK Ltd.
• B. Braun Medical Inc.
• Otsuka Pharmaceutical Co., Ltd.
• NexGen Health Inc
• JW Life Science Corporation
• Amanta Healthcare Ltd
• Baxter International Inc.
• Drip Hydration Inc.
• Becton, Dickinson and Company

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Intravenous (IV) Hydration Therapy Market is projected to expand from USD 3.16 Billion in 2025 to USD 4.97 Billion by 2031, registering a CAGR of 7.84%. This therapy involves administering fluids, electrolytes, vitamins, and medications directly into the bloodstream for immediate absorption and rapid systemic rehydration. Market growth is primarily fueled by the rising prevalence of chronic conditions necessitating nutritional support and a noticeable consumer shift toward proactive wellness and athletic recovery. This trajectory is bolstered by the spread of non-hospital service locations, including specialized wellness clinics and mobile infusion providers. Highlighting the sector's financial strength, the American Med Spa Association reported that in 2024, the average annual revenue for medical aesthetics practices-key providers of elective IV services-reached $1,398,833.

Despite this growth, the industry encounters substantial hurdles related to inconsistent regulatory oversight and safety compliance. As IV therapy transitions from clinical hospital environments to commercial settings, scrutiny regarding provider scope of practice and adherence to sterile compounding standards has increased. This complicated regulatory framework introduces liability risks and operational obstacles for new market entrants, potentially hindering the scalability of independent hydration services in regions with strict medical supervision mandates.

Market Driver

The rapid proliferation of medical spas and aesthetic wellness clinics serves as a major engine for market growth, effectively shifting IV therapy from an acute care treatment to a mainstream lifestyle service. This evolution is marked by the aggressive franchising of dedicated hydration centers and the incorporation of infusion services into established beauty businesses, thereby widening access for non-medical consumers. Validating the economic viability of these brick-and-mortar locations, SharpSheets reported in October 2025 within the 'Restore Hyper Wellness Franchise FDD, Profits & Costs (2025)' that the average annual revenue for a franchised studio is approximately $851,000. This physical footprint is significantly enhanced by technology-driven mobile services that bring treatments to homes and offices; Hydreight Technologies noted in their 'Corporate Update Highlighting Q3 Momentum' in December 2025 that quarterly revenue hit $10.52 million, a 132% year-over-year increase that underscores the scalability of decentralized models.

Concurrently, a growing consumer preference for preventive wellness is reshaping market demand, with individuals prioritizing immunity, cognitive function, and athletic performance over reactive healthcare. This trend is especially prominent among active professionals who utilize intravenous nutrition as a tool for routine optimization rather than merely for treating illness. This shift is quantitatively evident in booking patterns; the ClassPass '2025 Look Back Report' from December 2025 indicated that reservations for sports recovery sessions rose by 155% globally year-over-year. In response, providers are diversifying their offerings with specialized nutrient cocktails, firmly establishing IV therapy within the wider wellness economy and driving recurring, preventative usage.

Market Challenge

Inconsistent regulatory oversight and safety compliance standards create a volatile operational landscape that significantly hampers the scalability of the global intravenous hydration therapy market. As the industry moves from traditional hospital settings to commercial wellness centers and mobile units, regulators are enforcing stricter compliance with sterile compounding protocols and scope-of-practice laws. This fragmentation leads to confusion regarding facility standards and provider eligibility, compelling operators to navigate a complex and expensive legal environment that varies widely by jurisdiction. As a result, businesses are exposed to increased liability risks and are forced to allocate substantial capital toward legal compliance rather than service innovation or geographic growth.

These compliance obligations place a disproportionate burden on market expansion, which is fueled by a surge in service points that often lack the institutional infrastructure found in hospitals. The tension between aggressive commercial growth and rigid medical supervision requirements creates a significant bottleneck for new entrants attempting to satisfy consumer demand. The scale of this issue is reflected in the volume of facilities operating under such scrutiny; the American Med Spa Association projected that the number of medical spa facilities in the United States would reach 11,553 by 2025. With such a large and expanding network of providers, the lack of a unified regulatory standard serves as a direct impediment to industry consolidation and investor confidence.

Market Trends

A marked increase in demand for NAD+ and longevity-oriented protocols is reshaping the service landscape, signaling a shift from simple rehydration to advanced anti-aging interventions. Consumers are increasingly pursuing high-value "biohacking" treatments that offer cellular repair, mitochondrial support, and cognitive enhancement, prompting providers to broaden their offerings beyond standard vitamin cocktails. This trend is supported by strong financial results from key upstream suppliers; for instance, ChromaDex reported in its 'Fourth Quarter and Fiscal Year 2024 Results' in March 2025 that the company achieved net sales of $99.6 million, a 19% year-over-year increase largely driven by the rising adoption of its NAD+ precursor products in wellness and clinical applications.

At the same time, the industry is experiencing a structural evolution through the widespread implementation of subscription and membership-based business models. Operators are actively transitioning from transactional, acute-care revenue to recurring payment structures that provide predictable cash flow and improve long-term client retention. This strategy is proving effective for major market players; as noted by Athletech News in a May 2025 'Wellness & Recovery Outlook' article, Restore Hyper Wellness reported exceeding 57,000 active members and generating $200 million in system-wide annual sales for 2024. These membership programs encourage consistent utilization, effectively transforming sporadic users into committed lifestyle consumers.

Key Market Players

• Core IV Therapy, LLC
• Rejuvenated UK Ltd.
• B. Braun Medical Inc.
• Otsuka Pharmaceutical Co., Ltd.
• NexGen Health Inc
• JW Life Science Corporation
• Amanta Healthcare Ltd
• Baxter International Inc.
• Drip Hydration Inc.
• Becton, Dickinson and Company

Report Scope

In this report, the Global Intravenous (IV) Hydration Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Intravenous (IV) Hydration Therapy Market, By Service

• Immune Boosters
• Energy Boosters
• Skin Care
• Migraine
• Others

Intravenous (IV) Hydration Therapy Market, By Component

• Medicated
• Non-medicated

Intravenous (IV) Hydration Therapy Market, By End-Use Industry

• Hospitals & Clinics
• Wellness Centers & Spas
• Home Healthcare
• Others

Intravenous (IV) Hydration Therapy Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Intravenous (IV) Hydration Therapy Market.

Available Customizations:

Global Intravenous (IV) Hydration Therapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Intravenous (IV) Hydration Therapy Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Service (Immune Boosters, Energy Boosters, Skin Care, Migraine, Others)
  • 5.2.2. By Component (Medicated, Non-medicated)
  • 5.2.3. By End-Use Industry (Hospitals & Clinics, Wellness Centers & Spas, Home Healthcare, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Intravenous (IV) Hydration Therapy Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Service
  • 6.2.2. By Component
  • 6.2.3. By End-Use Industry
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Intravenous (IV) Hydration Therapy Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Service
      • 6.3.1.2.2. By Component
      • 6.3.1.2.3. By End-Use Industry
  • 6.3.2. Canada Intravenous (IV) Hydration Therapy Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Service
      • 6.3.2.2.2. By Component
      • 6.3.2.2.3. By End-Use Industry
  • 6.3.3. Mexico Intravenous (IV) Hydration Therapy Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Service
      • 6.3.3.2.2. By Component
      • 6.3.3.2.3. By End-Use Industry

7. Europe Intravenous (IV) Hydration Therapy Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Service
  • 7.2.2. By Component
  • 7.2.3. By End-Use Industry
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Intravenous (IV) Hydration Therapy Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Service
      • 7.3.1.2.2. By Component
      • 7.3.1.2.3. By End-Use Industry
  • 7.3.2. France Intravenous (IV) Hydration Therapy Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Service
      • 7.3.2.2.2. By Component
      • 7.3.2.2.3. By End-Use Industry
  • 7.3.3. United Kingdom Intravenous (IV) Hydration Therapy Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Service
      • 7.3.3.2.2. By Component
      • 7.3.3.2.3. By End-Use Industry
  • 7.3.4. Italy Intravenous (IV) Hydration Therapy Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Service
      • 7.3.4.2.2. By Component
      • 7.3.4.2.3. By End-Use Industry
  • 7.3.5. Spain Intravenous (IV) Hydration Therapy Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Service
      • 7.3.5.2.2. By Component
      • 7.3.5.2.3. By End-Use Industry

8. Asia Pacific Intravenous (IV) Hydration Therapy Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Service
  • 8.2.2. By Component
  • 8.2.3. By End-Use Industry
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Intravenous (IV) Hydration Therapy Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Service
      • 8.3.1.2.2. By Component
      • 8.3.1.2.3. By End-Use Industry
  • 8.3.2. India Intravenous (IV) Hydration Therapy Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Service
      • 8.3.2.2.2. By Component
      • 8.3.2.2.3. By End-Use Industry
  • 8.3.3. Japan Intravenous (IV) Hydration Therapy Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Service
      • 8.3.3.2.2. By Component
      • 8.3.3.2.3. By End-Use Industry
  • 8.3.4. South Korea Intravenous (IV) Hydration Therapy Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Service
      • 8.3.4.2.2. By Component
      • 8.3.4.2.3. By End-Use Industry
  • 8.3.5. Australia Intravenous (IV) Hydration Therapy Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Service
      • 8.3.5.2.2. By Component
      • 8.3.5.2.3. By End-Use Industry

9. Middle East & Africa Intravenous (IV) Hydration Therapy Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Service
  • 9.2.2. By Component
  • 9.2.3. By End-Use Industry
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Intravenous (IV) Hydration Therapy Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Service
      • 9.3.1.2.2. By Component
      • 9.3.1.2.3. By End-Use Industry
  • 9.3.2. UAE Intravenous (IV) Hydration Therapy Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Service
      • 9.3.2.2.2. By Component
      • 9.3.2.2.3. By End-Use Industry
  • 9.3.3. South Africa Intravenous (IV) Hydration Therapy Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Service
      • 9.3.3.2.2. By Component
      • 9.3.3.2.3. By End-Use Industry

10. South America Intravenous (IV) Hydration Therapy Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Service
  • 10.2.2. By Component
  • 10.2.3. By End-Use Industry
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Intravenous (IV) Hydration Therapy Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Service
      • 10.3.1.2.2. By Component
      • 10.3.1.2.3. By End-Use Industry
  • 10.3.2. Colombia Intravenous (IV) Hydration Therapy Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Service
      • 10.3.2.2.2. By Component
      • 10.3.2.2.3. By End-Use Industry
  • 10.3.3. Argentina Intravenous (IV) Hydration Therapy Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Service
      • 10.3.3.2.2. By Component
      • 10.3.3.2.3. By End-Use Industry

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Intravenous (IV) Hydration Therapy Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Core IV Therapy, LLC
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Rejuvenated UK Ltd.
• 15.3. B. Braun Medical Inc.
• 15.4. Otsuka Pharmaceutical Co., Ltd.
• 15.5. NexGen Health Inc
• 15.6. JW Life Science Corporation
• 15.7. Amanta Healthcare Ltd
• 15.8. Baxter International Inc.
• 15.9. Drip Hydration Inc.
• 15.10. Becton, Dickinson and Company

16. Strategic Recommendations

17. About Us & Disclaimer